Skip to main content
. 2021 Jul 2;20:132. doi: 10.1186/s12933-021-01322-6

Fig. 1.

Fig. 1

Effect of empagliflozin on BP and HR, a BP-systolic; b BP-diastolic; c HR, red – control group, blue – empagliflozin group. Data presented as individual measurements (empty symbols) and mean ± SD (filled symbols, n=6-8, for each time point) and analyzed using 2-way ANOVA with repeated measures.